Company profile
RoslinCT | Your advanced therapy solution
RoslinCT is a leading Cell and Gene Therapy Contract Development and Manufacturing Organisation providing services for companies developing cell and gene-based therapeutic products. Enabling you to bring your autologous or allogeneic therapy quickly to market.
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Jun 2020 to 31 Mar 2021
no public description
1 Oct 2018 to 31 Dec 2021
"Since their discovery in 2006, induced pluripotent stem cells (iPSC) have demonstrated their importance to disease modelling, drug discovery and regenerative medicine. Using genes/transcription factors associated with embryonic maintenance, 'adult' somatic cells are reprogrammed or induced to an embryonic-like state. This creates cells with the propertie...
1 Mar 2018 to 31 Mar 2022
"The Northern Alliance Advanced Therapies Treatment Centre (NAATTC) is a group of NHS hospitals and services. NAATTC has a wide geographical reach across Scotland and the North of England and is responsible for the health care of 15 million NHS patients. Advanced therapies are becoming increasingly available with a growing number of companies developing t...
1 Feb 2018 to 30 Apr 2020
ReNeuron is a biotechnology company that is experienced in developing cell therapy treatments for degenerative diseases such as stroke rehabilitation and diseases of the retina, such as retinitis pigmentosa (RP), for which there are no known treatments. In RP, the light detecting photoreceptor cells in the eye die gradually over a period of time, and the ...
